<DOC>
	<DOC>NCT00983775</DOC>
	<brief_summary>The purpose of this study is to compare the pharmacological profile of insulin administered with jet-injection with that of insulin injected with a conventional insulin pen.</brief_summary>
	<brief_title>Pharmacology of Insulin Injected With Jet-Injection</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin, Short-Acting</mesh_term>
	<criteria>Age 1850 years Bodymass index 1828 kg/m2 Blood pressure &lt;160/90 mmHg Stable glycaemic control with HbA1c 6.59.0% (for patients with type 1 diabetes mellitus) Duration of diabetes &gt;1 year (for patients with type 1 diabetes mellitus) Inability to provide informed consent Chronic use of medication other than oral contraceptives or thyroid hormone replacement therapy (with stable euthyroidism for at least 3 months) Chronic use of medication other than insulin or lowdose angiotensinconverting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) treatment (for patients with type 1 diabetes mellitus) Type 2 diabetes in firstdegree relatives (for healthy subjects) History of a major cardiovascular disease event (myocardial infarction, stroke, symptomatic peripheral artery disease, coronary bypass surgery, percutaneous coronary or peripheral artery angioplasty) Pregnancy Macroalbuminuria, i.e. urinary albumin excretion &gt;200 microg/min in collected urine sample or urinary albumintocreatinine ratio &gt;300 mg/g in spot urine sample (for patients with type 1 diabetes mellitus) Symptomatic diabetic neuropathy (for patients with type 1 diabetes mellitus) Proliferative diabetic retinopathy (a history of proliferative retinopathy that was successfully treated with laser coagulopathy is not an exclusion criterion) (for patients with type 1 diabetes mellitus)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Pharmacokinetic profile</keyword>
	<keyword>Pharmacodynamic profile</keyword>
	<keyword>insulin</keyword>
	<keyword>jet injector</keyword>
</DOC>